What Is TB-500?

TB-500 is a synthetic research peptide usually introduced through its relationship to thymosin beta-4, a small naturally occurring peptide known in cell biology for binding actin. This profile sets out what TB-500 is, how it relates to that parent peptide, and the kinds of research questions it appears in. It concerns the molecule and its study, and makes no statement about use.

The story begins with thymosin beta-4 and the recognition that a particular region of that peptide is tied to its actin-binding behaviour. TB-500 is described in connection with that region, and the laboratory material is made synthetically so a defined sequence can be prepared and studied. Our note on solid-phase peptide synthesis gives the relevant background.

TB-500 is a relatively short synthetic peptide whose interest comes less from its size than from the actin-binding chemistry of the thymosin beta-4 region it relates to. The material is handled as a lyophilised powder, as supplied on the TB-500 product page; for the building blocks involved, our note on amino acid classifications may help.

A little background on actin makes the research interest clearer. Actin is among the most abundant proteins in cells and forms part of the cytoskeleton, the internal scaffolding that gives a cell its shape and lets it move. The cytoskeleton is constantly assembling and disassembling, and peptides linked to actin binding are valued as tools for studying those dynamics under controlled conditions. That context is what places the thymosin beta-4 region, and TB-500 with it, inside cell-biology research, with foundational background in what is a peptide?

Thymosin beta-4 itself is studied largely for binding monomeric actin, the unpolymerised form, and so influencing the pool of actin available for the cytoskeleton to assemble from. That actin-handling role is the biological backdrop against which a related synthetic peptide is examined.

TB-500 draws attention chiefly because of the actin-binding biology linked to its parent peptide, which makes it useful for probing cytoskeletal processes such as cell shape and movement. One distinction runs through the whole topic: TB-500 is a synthetic peptide related to a region of a larger molecule, and observations about thymosin beta-4 do not automatically carry over to it. A related research peptide is introduced in what is BPC-157?, and the two are also offered as a combination within the research catalogue.

Work relevant to TB-500 sits inside the broader, well-established study of thymosin beta-4 and actin biology, though the synthetic peptide itself is best read carefully and at the level of the original studies. The TB-500 research overview takes up the investigated mechanisms and the limits of the evidence.

All products are supplied strictly for laboratory research use only. Not for human or animal consumption. Not a drug, supplement, or food. Not for diagnostic or therapeutic use. The material on this page is educational and factual: it summarises areas of published scientific investigation and general laboratory practice. It is not guidance for the use of any material in humans or animals, and nothing here should be read as a claim about safety, performance, or outcomes. Where a specific product specification or safety data sheet is provided with a material, that document is the definitive reference and takes precedence over any general information given here.